scorecardresearch
Wednesday, August 6, 2025
TopicSerum Institute of India

Topic: Serum Institute of India

In a 1st for US, its FDA approves at-home use of nasal flu vaccine; India’s version yet to gain traction

US's FluMist can now be administered by a healthcare provider or by recipient or caregiver aged 18 or above. India's Nasovac S4 faces hurdles like cost, availability & low acceptance.

How safe is AstraZeneca Covid vaccine & why there is no need to panic — some key questions answered

51 cases have been lodged in a UK court against biopharma company over claims that its Covid vaccine caused death and injury in several cases.

SII vaccine for deadly meningitis gets WHO nod on quality & safety, can now be procured by UN

MenFive targets 5 causes of meningococcal meningitis, a bacterial infection that can kill within hours. It can cause severe brain damage and sepsis, and is fatal in 50% cases if untreated.

In leg-up to vaccination, SII’s Covovax on CoWin as heterologous booster, to cost Rs 225

Amid rising infection, SII had sought the inclusion of Covovax as a heterologous booster on the CoWin web portal last week.

India vaccine against cervical cancer to be launched Thursday, ‘will combat global shortage’

The Serum Institute of India & Department of Biotechnology are set to launch the country's first indigenously developed Quadrivalent Human Papillomavirus vaccine against cervical cancer.

All about Serum Institute’s HPV vaccine, India’s 1st indigenous shot against cervical cancer

Pune-based SII has got the go-ahead from the Drugs Controller General of India to market the vaccine. Cervical cancer is one of the leading causes of female cancer mortality worldwide.

SII to manufacture India’s first qHPV vaccine against cervical cancer after DCGI approval

Cervical cancer in India is the 2nd most frequent cancer among women between 15-44 years of age. Currently, India is fully dependent on foreign manufacturers for the vaccine.

2nd Covid shot from Serum Institute, Rs 225/dose: All about Covovax, new jab approved for teens

Covovax, developed by US company Novavax & manufactured in India by Serum Institute, is a protein-based vaccine developed from SARS-CoV-2 strain.

Modi govt allows Serum Institute to export 50 lakh Covishield doses under COVAX to 4 nations

The SII will commence Covid vaccine export under the COVAX programme from 23 November. Nepal, Tajikistan, Mozambique and Bangladesh are the 4 nations that will receive the doses.

Serum Institute urges Modi govt to fast-track movement of increasing Covishield stock

SII's Director of Government and Regulatory Affairs is learnt to have recently communicated to Union Health Ministry that it has a manufactured stock of 24,89,15,000 Covishield doses.

On Camera

Tact, TACO, Time — 3Ts India must rely on to force Trump to back off for good

India has adopted a level-headed approach to Trump’s tariff rollercoaster — focusing on reaching an agreement over engaging in shenanigans.

BJP MPs go full throttle against Trump even as govt hails enduring India-US ties amid tariff tension

New Delhi: While the Indian government has made a measured response to the 25 percent trade tariff imposed by Donald Trump, many in the BJP...

Trump feared India could arm BrahMos with nuclear warhead to target Pakistan in Op Sindoor—WSJ report

New Delhi: During Operation Sindoor, the United States which had received intelligence suggesting that India had launched BrahMos cruise missiles to strike targets inside...

Pakistan, Dhaka have played Washington well. Back home, Modi ecosystem has an inner conflict

To protect ourselves from Trumpian diplomacy, first we must introspect the bipolarity within our establishment discourse.